Medicamen Biotech Ltd. NSE: MEDICAMEQ | BSE: 531146

Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.062916625
Author: Trendlyne DVM scores

Slowing Down Stock

about

Medicamen Biotech is engaged in Generic Finished Dosage Forms, Oncology Formulations and Research & Development services to cater to the needs of the Global Pharmaceuticals Industry.

303.55 -21.50 (-6.61%)

New 52W Low today

117.4K

NSE+BSE Volume

High volume+loss today

NSE 26 Sep, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Mid Valuation

35.8 / 100

Technically Bearish

29.2 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Medicamen Biotech is engaged in Generic Finished Dosage Forms, Oncology Formulations and Research & Development services to cater to the needs of the Global Pharmaceuticals Industry.

New 52W Low today

High volume+loss today

SWOT Analysis

Medicamen Biotech Live Price Chart